Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07251348

Progressive Relaxation and Psychoeducation in Patients With Hematological Malignancies

This study will be conducted to determine the effect of progressive relaxation and psychoeducation on perceived stress and hope in patients with hematological malignancies

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Seydişehir Kamil Akkanat Sağlik Bilimleri Fakültesi

Konya, Seydi̇şehi̇r, 42000, Turkey (Türkiye)

About this study

Being healthy requires being in a state of complete physical and mental well-being. Therefore, mental and physical well-being must be maintained together. While each individual already has different stressors, the fact that hematological malignancies are chronic and immune-mediated diseases increases the stress factors perceived by individuals, and the difficulty and uncertainty of the process reduces their level of hope. This triggers the use of ineffective coping methods. Patients with high perceived stress levels and declining hope levels are unable to adequately manage the disease process. Consequently, mortality and morbidity rates increase. This experimentally planned study will be conducted between February 2026 and November 2026 at the Adult Inpatient Hematology Clinic of Gazi University Faculty of Medicine Hospital. The study will involve 75 individuals hospitalized at the clinic who meet the inclusion criteria. It is a non-randomized study with 2 intervention groups and 1 control group. Intervention group A (progressive relaxation group, n=25), intervention group B (psychoeducation, n=25), and control group (routine care, n=25). Patients in intervention group A will undergo a 3-week, 6-session progressive relaxation exercise program, conducted individually and face-to-face. Intervention Group B will receive a 3-week, 6-session, individual, face-to-face psychoeducation program. The control group will receive 3 weeks of routine nursing care identical to that provided to the other groups. In this study, which will include pre- and post-tests, data will be collected face-to-face using the perceived stress level scale and the Herth hope index scale. The primary objective of this study is to examine the effects of progressive relaxation and psychoeducation interventions on perceived stress and hope levels in patients with hematological malignancies.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older
  • Diagnosis of hematologic malignancy
  • Ability to read and write
  • Volunteer to participate in the study

Exclusion criteria

  • Dementia and/or organic mental disorder
  • Sensory loss related to vision and hearing
  • Communication barrier
  • Physical disability
  • Respiratory distress
  • Bone marrow transplant procedure

Treatment and study plan

Muscle Relaxation

Behavioral

Progressive relaxation is a relaxation technique based on tensing and relaxing muscles in sequence. The goal is to achieve physical and mental relaxation by feeling the difference between tension and relaxation. It is frequently used for stress, anxiety, sleep problems, and psychosomatic disorders. When practiced regularly, it increases a person's ability to relax and contributes to their overall well-being.

  • Teaching progressive relaxation exercises to individuals diagnosed with cancer and supporting psychological well-being by reducing stress levels and increasing hope levels through these exercises (emotional gain)
  • Reducing muscle tension and providing physical relaxation (psychomotor gain)
  • To reduce stress and anxiety (emotional gain)
  • To increase body awareness (emotional gain)
  • To teach mental and physical relaxation (psychomotor gain)
  • To provide emotional relief (emotional gain)
  • To develop self-relaxation skills (psychomotor gain)

psychoeducation or Atomoxetine or stimulants according to ADHD severity

Behavioral

Psychoeducation is a structured educational process that provides individuals with information about mental illnesses, ways to cope with stress, and healthy living skills. The goal is to help the person understand their illness and symptoms, learn coping methods, and increase their compliance with treatment. It has both an informative and a supportive aspect.

INTERVENTION B (PSYCHOEDUCATION) GROUP APPLICATION:

  • A total of 6 sessions will be held with patients in intervention group B, twice a week for 3 weeks.
  • Each session will last an average of 45 minutes.
  • The 'Perceived Stress Level' scale and the 'Herth Hope Index' scale will be administered after the first session.
  • The 'Perceived Stress Level' scale and the 'Herth Hope Index' scale will be administered after the final session.

Primary outcomes

  1. Herth hope index level scale

    Time frame: 9 months

    Herth Hope Index: Developed by Kaye Herth (1992), its validity and reliability in Turkish were studied by Aslan and colleagues (2007). The scale consists of a total of 12 items: "Future" (questions 1, 2, 6, 11), "Positive readiness and expectation" (questions 4, 7, 10, 12), and "Connections with oneself and others" (questions 3, 5, 8, 9).

  2. perceived stress level scales

    Time frame: 9 months

    PERCEIVED STRESS SCALE: The adaptation of the perceived stress scale developed by Cohen, Kamarck, and Mermelsten (1983) into Turkish was carried out by Eskin et al. (2013). The perceived stress scale, consisting of a total of 14 items, aims to measure how stressful individuals perceive their life situations to be..

Sponsors and collaborators

Lead sponsor

Necmettin Erbakan University

Other

Registry information

Official study title

The Effect of Progressive Relaxation and Psychoeducation on Perceived Stress and Hope in Patients With Hematologic Malignancies: A Non-Randomized Study

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Nov 26, 2025
Registry last updated
May 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.